Advertisement

Stroke in the patient with diabetes (part 1) – Epidemiology, etiology, therapy and prognosis

      Abstract

      There is a higher incidence of stroke in both the type 2 diabetic and the non-diabetic insulin resistant patient which is accompanied by higher morbidity and mortality. The increase in the frequency of stroke is due to an increase in cerebral infarction, mainly lacunar infarcts, with the incidence of cerebral hemorrhage being less frequent. The major risk factors for stroke in the type 2 diabetic patient are age, hypertension, the number of features of the Metabolic Syndrome, the presence of diabetic nephropathy in both the type 1 and type 2 patient, the presence of peripheral and coronary artery disease and especially the presence of atrial fibrillation. Hyperglycemia is associated with a poor outcome from stroke but is not causative.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Diabetes Research and Clinical Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Norrving B.
        • Kissela B.
        The global burden of stroke and need for a continuum of care.
        Neurology. 2013; 80: S5-S12
        • Yao X.Y.
        • Jiang C.Q.
        • Jia G.L.
        • Chen G.
        Diabetes mellitus and the risk of aneurysmal subarachnoid haemorrhage: A systematic review and meta-analysis of current evidence.
        J Int Med Res. 2016; 44: 1141-1155
        • Karapanayiotides T.
        • Piechowski-Jozwiak B.
        • van Melle G.
        • Bogousslavsky J.
        • Devuyst G.
        Stroke patterns, etiology, and prognosis in patients with diabetes mellitus.
        Neurology. 2004; 62: 1558-1562
        • O'Donnell M.J.
        • Xavier D.
        • Liu L.
        • et al.
        Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study.
        Lancet. 2010; 376: 112-123
        • Wolf P.A.
        • Kannel W.B.
        • Verter J.
        Current status of risk factors for stroke.
        Neurol Clin. 1983; 1: 317-343
        • Khoury J.C.
        • Kleindorfer D.
        • Alwell K.
        • et al.
        Diabetes mellitus: a risk factor for ischemic stroke in a large biracial population.
        Stroke. 2013; 44: 1500-1504
        • Cui R.
        • Iso H.
        • Yamagishi K.
        • et al.
        Diabetes mellitus and risk of stroke and its subtypes among Japanese: the Japan public health center study.
        Stroke. 2011; 42: 2611-2614
        • Manolio T.A.
        • Kronmal R.A.
        • Burke G.L.
        • O'Leary D.H.
        • Price T.R.
        Short-term predictors of incident stroke in older adults. The Cardiovascular Health Study.
        Stroke. 1996; 27: 1479-1486
        • Davis P.H.
        • Dambrosia J.M.
        • Schoenberg B.S.
        • et al.
        Risk factors for ischemic stroke: a prospective study in Rochester, Minnesota.
        Ann Neurol. 1987; 22: 319-327
        • Janghorbani M.
        • Hu F.B.
        • Willett W.C.
        • et al.
        Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes: the Nurses' Health Study.
        Diabetes Care. 2007; 30: 1730-1735
        • Hagg S.
        • Thorn L.M.
        • Putaala J.
        • et al.
        Incidence of stroke according to presence of diabetic nephropathy and severe diabetic retinopathy in patients with type 1 diabetes.
        Diabetes Care. 2013; 36: 4140-4146
        • Bell D.S.H.
        • Goncalves E.
        Atrial fibrillation and type 2 diabetes: Prevalence, etiology, pathophysiology and effect of anti-diabetic therapies.
        Diabetes Obes Metab. 2019; 21: 210-217
        • Pullicino P.M.
        • Xuereb M.
        • Aquilina J.
        • Piedmonte M.R.
        Stroke following acute myocardial infarction in diabetics.
        J Intern Med. 1992; 231: 287-293
        • Weinberger J.
        Prevention of ischemic stroke.
        Curr Treat Options Cardiovasc Med. 2002; 4: 393-403
        • Dilic M.
        • Dzubur A.
        • Kusljugic Z.
        • Balic S.
        • Pepic E.
        Correlation of arterial hypertension and type 2 diabetes mellitus with type of polyvascular atherosclerotic disease.
        Med Arh. 2010; 64: 264-268
        • Aronson S.M.
        Intracranial vascular lesions in patients with diabetes mellitus.
        J Neuropathol Exp Neurol. 1973; 32: 183-196
        • Alex M.
        • Baron E.K.
        • Goldenberg S.
        • Blumenthal H.T.
        An autopsy study of cerebrovascular accident in diabetes mellitus.
        Circulation. 1962; 25: 663-673
        • Bell E.T.
        A postmortem study of vascular disease in diabetics.
        AMA Arch Pathol. 1952; 53: 444-455
        • Rutten-Jacobs L.C.A.
        • Markus H.S.
        Study UKYLSD vascular risk factor profiles differ between magnetic resonance imaging-defined subtypes of younger-onset lacunar stroke.
        Stroke. 2017; 48: 2405-2411
        • Dandona P.
        • James I.M.
        • Newbury P.A.
        • Woollard M.L.
        • Beckett A.G.
        Cerebral blood flow in diabetes mellitus: evidence of abnormal cerebrovascular reactivity.
        Br Med J. 1978; 2: 325-326
        • Burn W.K.
        • Machin D.
        • Waters W.E.
        Prevalence of migraine in patients with diabetes.
        Br Med J (Clin Res Ed). 1984; 289: 1579-1580
        • Wang X.
        • Li X.
        • Diao Y.
        • et al.
        Are glucose and insulin metabolism and diabetes associated with migraine? A community-based, case-control study.
        J Oral Facial Pain Headache. 2017; 31: 240-250
        • Bell D.S.
        Hypertension and diabetes: a toxic combination.
        Endocr Pract. 2008; 14: 1031-1039
        • Barrett-Connor E.
        • Khaw K.T.
        Diabetes mellitus: an independent risk factor for stroke?.
        Am J Epidemiol. 1988; 128: 116-123
        • Bell D.S.
        Hypertension in the person with diabetes.
        Am J Med Sci. 1989; 297: 228-232
        • Bell D.S.
        Treatment of diabetic hypertension.
        Diabetes Obes Metab. 2009; 11: 433-444
      1. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317(7160):703-713.

        • Holman R.R.
        • Paul S.K.
        • Bethel M.A.
        • Neil H.A.
        • Matthews D.R.
        Long-term follow-up after tight control of blood pressure in type 2 diabetes.
        N Engl J Med. 2008; 359: 1565-1576
        • Buckley Leo F.
        • Dixon Dave L.
        • Wohlford IV, George F.
        • Wijesinghe Dayanjan S.
        • Baker William L.
        • Van Tassell Benjamin W.
        Effect of intensive blood pressure control in patients with type 2 diabetes mellitus over 9 years of follow-up: A subgroup analysis of high-risk ACCORDION trial participants.
        Diabetes Obes Metab. 2018; 20: 1499-1502https://doi.org/10.1111/dom.2018.20.issue-610.1111/dom.13248
        • Leung W.K.
        • Gao L.
        • Siu P.M.
        • Lai C.W.
        Diabetic nephropathy and endothelial dysfunction: Current and future therapies, and emerging of vascular imaging for preclinical renal-kinetic study.
        Life Sci. 2016; 166: 121-130
        • Asplund K.
        • Hagg E.
        • Helmers C.
        • Lithner F.
        • Strand T.
        • Wester P.O.
        The natural history of stroke in diabetic patients.
        Acta Med Scand. 1980; 207: 417-424
        • Kagan A.
        • Popper J.S.
        • Rhoads G.G.
        Factors related to stroke incidence in Hawaii Japanese men. The honolulu heart study.
        Stroke. 1980; 11: 14-21
        • Colhoun H.M.
        • Betteridge D.J.
        • Durrington P.N.
        • et al.
        Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.
        Lancet. 2004; 364: 685-696
        • Waters D.D.
        • LaRosa J.C.
        • Barter P.
        • et al.
        Effects of high-dose atorvastatin on cerebrovascular events in patients with stable coronary disease in the TNT (treating to new targets) study.
        J Am Coll Cardiol. 2006; 48: 1793-1799
        • Diabetes C.
        Complications Trial /Epidemiology of Diabetes I, Complications Study Research G. Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up.
        Diabetes Care. 2016; 39: 686-693
        • Stratton I.M.
        • Adler A.I.
        • Neil H.A.
        • et al.
        Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
        BMJ. 2000; 321: 405-412
        • Holman R.R.
        • Paul S.K.
        • Bethel M.A.
        • Matthews D.R.
        • Neil H.A.
        10-year follow-up of intensive glucose control in type 2 diabetes.
        N Engl J Med. 2008; 359: 1577-1589
        • Li W.
        • Katzmarzyk P.T.
        • Horswell R.
        • et al.
        Body mass index and stroke risk among patients with type 2 diabetes mellitus.
        Stroke. 2015; 46: 164-169
        • Dale C.E.
        • Fatemifar G.
        • Palmer T.M.
        • et al.
        Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization Analysis.
        Circulation. 2017; 135: 2373-2388
        • Shen Y.
        • Shi L.
        • Nauman E.
        • et al.
        Inverse association between HDL (high-density lipoprotein) cholesterol and stroke risk among patients with type 2 diabetes mellitus.
        Stroke. 2019; 50: 291-297
        • Lee J.S.
        • Chang P.Y.
        • Zhang Y.
        • Kizer J.R.
        • Best L.G.
        • Howard B.V.
        Triglyceride and HDL-C dyslipidemia and risks of coronary heart disease and ischemic stroke by glycemic dysregulation status: the strong heart study.
        Diabetes Care. 2017; 40: 529-537
        • Zhong C.
        • Zhong X.
        • Xu T.
        • Xu T.
        • Zhang Y.
        Sex-specific relationship between serum uric acid and risk of stroke: a dose-response meta-analysis of prospective studies.
        J Am Heart Assoc. 2017; 6
        • Ago T.
        • Matsuo R.
        • Hata J.
        • et al.
        Insulin resistance and clinical outcomes after acute ischemic stroke.
        Neurology. 2018; 90: e1470-e1477
        • Merger S.R.
        • Kerner W.
        • Stadler M.
        • et al.
        Prevalence and comorbidities of double diabetes.
        Diabetes Res Clin Pract. 2016; 119: 48-56
        • Aminian A.
        • Aleassa E.M.
        • Bhatt D.L.
        • et al.
        Bariatric surgery is associated with a lower rate of death after myocardial infarction and stroke: A nationwide study.
        Diabetes Obes Metab. 2019; 21: 2058-2067
        • Morgan C.L.
        • Inzucchi S.E.
        • Puelles J.
        • Jenkins-Jones S.
        • Currie C.J.
        Impact of treatment with pioglitazone on stroke outcomes: A real-world database analysis.
        Diabetes Obes Metab. 2018; 20: 2140-2147
        • Baalbaki H.A.
        • Bell D.S.
        Insulin resistance and thrombogenesis: recent insights and therapeutic implications.
        Endocr Pract. 2007; 13: 679-686
        • Bell D.S.
        Inflammation, insulin resistance, infection, diabetes, and atherosclerosis.
        Endocr Pract. 2000; 6: 272-276
        • Gilman S.
        Advances in neurology (2).
        N Engl J Med. 1992; 326: 1671-1676
        • Bell D.S.
        Stroke in the diabetic patient.
        Diabetes Care. 1994; 17: 213-219
        • Sugawara E.
        • Kudo Y.
        • Johkura K.
        Hypoglycemic hemiplegia.
        Brain Nerve. 2017; 69: 101-110
        • Wallis W.E.
        • Donaldson I.
        • Scott R.S.
        • Wilson J.
        Hypoglycemia masquerading as cerebrovascular disease (hypoglycemic hemiplegia).
        Ann Neurol. 1985; 18: 510-512
        • Rawshani A.
        • Rawshani A.
        • Franzen S.
        • et al.
        Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes.
        N Engl J Med. 2018; 379: 633-644
        • Hu G.C.
        • Hsieh S.F.
        • Chen Y.M.
        • Hu Y.N.
        • Kang C.L.
        • Chien K.L.
        The prognostic roles of initial glucose level and functional outcomes in patients with ischemic stroke: difference between diabetic and nondiabetic patients.
        Disabil Rehabil. 2012; 34: 34-39
        • Berger L.
        • Hakim A.M.
        The association of hyperglycemia with cerebral edema in stroke.
        Stroke. 1986; 17: 865-871
        • Gray C.S.
        • Taylor R.
        • French J.M.
        • et al.
        The prognostic value of stress hyperglycaemia and previously unrecognized diabetes in acute stroke.
        Diabet Med. 1987; 4: 237-240
        • Pulsinelli W.A.
        • Levy D.E.
        • Sigsbee B.
        • Scherer P.
        • Plum F.
        Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus.
        Am J Med. 1983; 74: 540-544
        • Freiberg J.J.
        • Tybjaerg-Hansen A.
        • Jensen J.S.
        • Nordestgaard B.G.
        Nonfasting triglycerides and risk of ischemic stroke in the general population.
        JAMA. 2008; 300: 2142-2152
        • Bell D.S.
        • O'Keefe J.H.
        • Jellinger P.
        Postprandial dysmetabolism: the missing link between diabetes and cardiovascular events?.
        Endocr Pract. 2008; 14: 112-124
        • McCall A.L.
        The impact of diabetes on the CNS.
        Diabetes. 1992; 41: 557-570
        • Smith M.L.
        • von Hanwehr R.
        • Siesjo B.K.
        Changes in extra- and intracellular pH in the brain during and following ischemia in hyperglycemic and in moderately hypoglycemic rats.
        J Cereb Blood Flow Metab. 1986; 6: 574-583
        • Rothman S.M.
        • Olney J.W.
        Glutamate and the pathophysiology of hypoxic–ischemic brain damage.
        Ann Neurol. 1986; 19: 105-111
        • Gisselsson L.
        • Smith M.L.
        • Siesjo B.K.
        Hyperglycemia and focal brain ischemia.
        J Cereb Blood Flow Metab. 1999; 19: 288-297
        • Ergul A.
        • Li W.
        • Elgebaly M.M.
        • Bruno A.
        • Fagan S.C.
        Hyperglycemia, diabetes and stroke: focus on the cerebrovasculature.
        VascPharmacol. 2009; 51: 44-49
        • Pandolfi A.
        • Giaccari A.
        • Cilli C.
        • et al.
        Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat.
        Acta Diabetol. 2001; 38: 71-76
        • Weir C.J.
        • Murray G.D.
        • Dyker A.G.
        • Lees K.R.
        Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study.
        BMJ. 1997; 314: 1303-1306
        • Jauch E.C.
        • Saver J.L.
        • Adams Jr, H.P.
        • et al.
        Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
        Stroke. 2013; 44: 870-947
      2. European Stroke Initiative Executive C, Committee EW, Olsen TS, et al. European Stroke Initiative Recommendations for Stroke Management-update 2003. Cerebrovasc Dis. 2003;16(4):311-337.

        • Johnston K.C.
        • Bruno A.
        • Pauls Q.
        • et al.
        Intensive vs standard treatment of hyperglycemia and functional outcome in patients with acute ischemic stroke: the SHINE randomized clinical trial.
        JAMA. 2019; 322: 326-335
        • Powers W.J.
        • Rabinstein A.A.
        • Ackerson T.
        • et al.
        2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American heart association/american stroke association.
        Stroke. 2018; 49: e46-e110
        • Nikneshan D.
        • Raptis R.
        • Pongmoragot J.
        • et al.
        Predicting clinical outcomes and response to thrombolysis in acute stroke patients with diabetes.
        Diabetes Care. 2013; 36: 2041-2047
        • Parlani G.
        • De Rango P.
        • Cieri E.
        • et al.
        Diabetes is not a predictor of outcome for carotid revascularization with stenting as it may be for carotid endarterectomy.
        J Vasc Surg. 2012; 55: 79-89